Ventria Bioscience develops life-saving medicines targeting inflammatory, infectious and gastrointestinal diseases. It produces medicinal products that are enabled by ExpressTec, a breakthrough in biomanufacturing that is meant to enable global access and affordability. The Company also sells animal-component-free cell culture reagents and designs animal-component-free cell culture media formulations for cell-based vaccines, cellular therapies and biomanufacturing.